Combination therapy comprising sglt inhibitors and dpp4...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7056 (2006.01) A61K 31/401 (2006.01) A61K 31/496 (2006.01) A61K 31/4985 (2006.01) A61K 31/7042 (2006.01) A61K 31/706 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2712614

The present invention relates to combination therapy comprising a DPP4 inhibitor and an SGLT inhibitor. The combination of the present invention leads to increase plasma GLP-1 level and the combination is useful for prevention or treatment of conditions such as diabetes and diseases related to diabetes.

La présente invention porte sur une thérapie d'association comprenant un inhibiteur de la DPP4 et un inhibiteur de SGLT. L'association de la présente invention conduit à une augmentation du taux de GLP-1 dans le plasma, et l'association est utile dans la prévention ou le traitement d'états tels que le diabète et de maladies se rapportant au diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy comprising sglt inhibitors and dpp4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy comprising sglt inhibitors and dpp4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy comprising sglt inhibitors and dpp4... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2016660

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.